Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 03, 2023

BUY
$32.09 - $37.51 $42,519 - $49,700
1,325 Added 15.67%
9,778 $324,000
Q2 2023

Jul 17, 2023

BUY
$36.12 - $41.79 $61,765 - $71,460
1,710 Added 25.36%
8,453 $310,000
Q1 2023

May 02, 2023

SELL
$39.39 - $51.28 $2,166 - $2,820
-55 Reduced 0.81%
6,743 $275,000
Q4 2022

Feb 02, 2023

SELL
$41.75 - $54.5 $25,592 - $33,408
-613 Reduced 8.27%
6,798 $348,000
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $53,080 - $64,798
1,213 Added 19.57%
7,411 $324,000
Q1 2022

May 03, 2022

SELL
$45.75 - $56.69 $1,235 - $1,530
-27 Reduced 0.43%
6,198 $321,000
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $257,217 - $381,281
6,225 New
6,225 $368,000
Q3 2021

Nov 03, 2021

SELL
$39.25 - $50.42 $241,112 - $309,730
-6,143 Closed
0 $0
Q2 2021

Jul 21, 2021

SELL
$35.91 - $40.68 $108,268 - $122,650
-3,015 Reduced 32.92%
6,143 $241,000
Q1 2021

Apr 13, 2021

SELL
$33.49 - $37.77 $338,818 - $382,119
-10,117 Reduced 52.49%
9,158 $332,000
Q4 2020

Feb 08, 2021

SELL
$33.47 - $42.56 $21,521 - $27,366
-643 Reduced 3.23%
19,275 $710,000
Q3 2020

Oct 19, 2020

SELL
$31.75 - $37.25 $13,684 - $16,054
-431 Reduced 2.12%
19,918 $731,000
Q2 2020

Jul 29, 2020

SELL
$30.12 - $36.54 $10,993 - $13,337
-365 Reduced 1.76%
20,349 $665,000
Q1 2020

Jul 28, 2020

SELL
$27.03 - $38.62 $33,625 - $48,043
-1,244 Reduced 5.67%
20,714 $676,000
Q4 2019

Jul 28, 2020

BUY
$32.92 - $37.36 $722,857 - $820,350
21,958 New
21,958 $860,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Carl P. Sherr & Co., LLC Portfolio

Follow Carl P. Sherr & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carl P. Sherr & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carl P. Sherr & Co., LLC with notifications on news.